Search research articles
Contact Us
Filters
Showing results (181-190 of 204) with videos related to
Page
of 21
Sort By:
Genome Biology
|
December 26, 2013
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition
Gabriel G Malouf, Joseph H Taube, Yue Lu, et al.
The Lancet. Oncology
|
August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Jean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
Scientific Reports
|
September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
Joseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Cancer Research
|
November 6, 2009
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma
Yasuhiro Goto, Keiko Shinjo, Yutaka Kondo, et al.
Clinical Epigenetics
|
May 14, 2020
Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis
Jee Yeon Kim, Bong-Geun Choi, Jaroslav Jelinek, et al.
The Lancet. Haematology
|
May 8, 2019
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial
Guillermo Garcia-Manero, Gail Roboz, Katherine Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate
Hagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Plos One
|
November 1, 2023
Postmortem toxicology findings from the Camden Opioid Research Initiative
Dara M Kusic, Jessica Heil, Stefan Zajic, et al.
Cancer
|
December 7, 2017
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia
Gail J Roboz, Hagop M Kantarjian, Karen W L Yee, et al.
Cancer Research
|
January 1, 2016
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer
Noël J-M Raynal, Justin T Lee, Youjun Wang, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 204) with videos related to
Sort By:
Page
of 21
Genome Biology
|
December 26, 2013
Architecture of epigenetic reprogramming following Twist1-mediated epithelial-mesenchymal transition
Gabriel G Malouf, Joseph H Taube, Yue Lu, et al.
The Lancet. Oncology
|
August 23, 2015
Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study
Jean-Pierre J Issa, Gail Roboz, David Rizzieri, et al.
Scientific Reports
|
September 19, 2013
Epigenetic silencing of microRNA-203 is required for EMT and cancer stem cell properties
Joseph H Taube, Gabriel G Malouf, Emily Lu, et al.
Cancer Research
|
November 6, 2009
Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma
Yasuhiro Goto, Keiko Shinjo, Yutaka Kondo, et al.
Clinical Epigenetics
|
May 14, 2020
Promoter methylation changes in ALOX12 and AIRE1: novel epigenetic markers for atherosclerosis
Jee Yeon Kim, Bong-Geun Choi, Jaroslav Jelinek, et al.
The Lancet. Haematology
|
May 8, 2019
Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial
Guillermo Garcia-Manero, Gail Roboz, Katherine Walsh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
Treatment of philadelphia chromosome-positive, accelerated-phase chronic myelogenous leukemia with imatinib mesylate
Hagop M Kantarjian, Susan O'Brien, Jorge E Cortes, et al.
Plos One
|
November 1, 2023
Postmortem toxicology findings from the Camden Opioid Research Initiative
Dara M Kusic, Jessica Heil, Stefan Zajic, et al.
Cancer
|
December 7, 2017
Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia
Gail J Roboz, Hagop M Kantarjian, Karen W L Yee, et al.
Cancer Research
|
January 1, 2016
Targeting Calcium Signaling Induces Epigenetic Reactivation of Tumor Suppressor Genes in Cancer
Noël J-M Raynal, Justin T Lee, Youjun Wang, et al.
Page
of 21